LIFE compared with PRME: revenue, margins and what each company keeps, and the suppliers and customers both name

LIFEEthos Technologies Inc.

Mkt capRevenueRevenue

PRMEPrime Medicine, Inc.

Mkt capRevenueRevenue

Compare

LIFEEthos Technologies Inc.

PRMEPrime Medicine, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LIFE2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±18.7%▼−4.08%×0.22

Q2 FY26—▲+21.11%—

PRME

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.2%▼−4.22%×0.30

May 7 '26±15.5%▼−8.65%×0.56

= impliedLIFE realized, solidPRME realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedspan: LIFE 91d · PRME 272dSource: market data

Q1 FY26

±18.4%

▼−9.23%

×0.50

Q3 FY25±17.6%▼−8.85%×0.50

LIFEEthos Technologies Inc.

33.48▲+2.63%· post 33.47

Mkt cap$2.3BRevenue$235MQ3 FY26Revenue—

PRMEPrime Medicine, Inc.

4.65▲+4.41%· post 4.65

ClosedNov 6 '26

Mkt cap—Revenue$1MQ2 FY26Revenue$5MFY25

Compare

ClosedNov 6 '26

LIFEEthos Technologies Inc.

PRMEPrime Medicine, Inc.

33.48▲+2.63%post 33.47

Price

4.65▲+4.41%post 4.65

$2.3B

Mkt cap

—

Q3 FY26$235M

Revenue

$1MQ2 FY26

—

Revenue

$5MFY25

LIFE33.48▲+2.63%vsPRME4.65▲+4.41%ClosedNov 6 '26